June 22, 2011

The Food and Drug Administration has approved a medication designed to treat acute and chronic moderate to severe pain, where the use of an opioid analgesic is suitable.

June 20, 2011

The overall growth in drug spending for 2010 was 3.7%, according to the latest drug trend report by pharmacy benefit manager Medco Health Solutions. The lower increase 
was primarily due to higher rates of generic drug dispensing — more than 71% of drugs dispensed were generics. 


June 13, 2011

Merck will collaborate with a Korean manufacturer to develop a biosimilar version of a drug used for autoimmune diseases.

June 7, 2011

Dr. Reddy's Labs has received regulatory approval from the Food and Drug Administration for generic versions of treatments for Alzheimer's disease, depression and breast cancer.

June 7, 2011

Global Wellness on Tuesday initiated a voluntary nationwide recall of its Via Extreme ultimate sexual enhancer dietary supplement for men.

June 7, 2011

The Food and Drug Administration has approved a generic contraceptive made by Watson Pharmaceuticals, the company said Tuesday.

June 3, 2011

Pfizer has filed suit against generic drug maker Impax Labs in connection with the latter’s attempt to market a generic drug for bladder problems.

June 3, 2011

Generic drug maker Watson Labs is hoping to market a generic version of a Pfizer drug for erectile dysfunction.

June 2, 2011

The Food and Drug Administration has approved a generic drug for depression and anxiety made by Mylan, the drug maker said Thursday.

June 2, 2011

The Food and Drug Administration has approved a generic drug for Alzheimer’s disease made by Teva Pharmaceutical Industries.

June 1, 2011

The Food and Drug Administration has approved a generic treatment for Alzheimer’s disease made by Actavis, the drug maker said Tuesday.

June 1, 2011

Sandoz has launched generic versions of treatments for Alzheimer’s disease, the generic pharmaceuticals division of Swiss drug maker Novartis said Wednesday.

May 24, 2011

The Food and Drug Administration has approved a generic over-the-counter treatment for allergies made by Taro Pharmaceutical Industries.

May 23, 2011

The summer 2011 Allergy Relief Ingredient Guide breaks down the indication, active ingredients, purpose and dosage of such OTC allergy-symptom relievers as Claritin, Allegra, Zyrtec, Benadryl, Hyland's, Ocean, Similasan, Visine A.C. and Zaditor.

May 23, 2011

The FDA has approved a new treatment for Type 2 diabetes, the agency said. The FDA announced the approval of Tradjenta (linagliptin) made by Indianapolis-based Eli Lilly and German drug maker Boehringer Ingelheim.


May 23, 2011

The Food and Drug Administration has approved a Pfizer drug for treating pancreatic tumors.

May 10, 2011

The Food and Drug Administration expects to approve an increasing number of drugs, according to published reports.

May 6, 2011

Greenstone has introduced an authorized generic treatment for breast cancer, the generics subsidiary of Pfizer said.

May 5, 2011

A major depressive disorder treatment made by Pfizer significantly reduced the number and severity of moderate-to-severe hot flashes in postmenopausal women, compared with placebo, according to a new study.

May 4, 2011

Visine is looking to help consumers that experience eye irritation and redness during the summer months.

May 3, 2011

Sales at generic drug maker Mylan increased by 12% during first quarter 2011, compared with first quarter 2010, the company said Tuesday.

April 27, 2011

Pfizer on Wednesday launched its Gold range of child nutrition products, developed to meet the changing nutritional and feeding needs of young children. The Gold range of infant and follow-on formulas and growing-up milks provides the right balance of high-quality nutrients needed to support ideal health, growth and development in growing children.

April 26, 2011

The American Pharmacists Association on Monday released its 2010 Pharmacy Today over-the-counter product survey and found that 92% of pharmacists walk a patient to the OTC section to assist with a product selection, noting that the average patient consult takes only three minutes of the patient's time.

April 14, 2011

Drug manufacturers are coming up with new versions of their drugs for erectile dysfunction as those drugs’ loss of patent protection and subsequent generic competition draw near, according to published reports.